Session 130 - 13th CROI

Home

Session 130 Poster Abstracts
Metabolic Syndrome and Other Abnormalities of Fat, Lipid, Glucose and Bone Metabolism
Wednesday, 1:30 - 3:30 pm
Poster Hall

746	Metabolic Analyses within A5095: Effect of Efavirenz against an All-nucleoside/Nucleotide Background Cecilia Shikuma*¹, Y Yang², W Meyer³, M Glesby⁴, K Tashima⁵, H Ribaudo², N Webb⁶, B Bastow⁷, D Kuritzkes⁸, R Gulick⁴, and AIDS Clin Trials Group A5095 Study Team ¹Univ of Hawaii, Honolulu, US; ²Harvard Sch of Publ Hlth, Boston, MA, US; ³Quest Diagnostics, Baltimore, MD, US; ⁴Cornell Univ, New York, NY, US; ⁵Brown Univ, Providence, RI, US; ⁶Frontier Sci & Tech Res Fndn, Amherst, NY, US; ⁷Social & Sci Systems, Silver Spring, MD, US; and ⁸Harvard Sch of Publ Hlth, Cambridge, MA, US
747	Correlates of the Metabolic Syndrome among HIV Seropositive and Seronegative Men in the Multicenter AIDS Cohort Study Frank Palella*¹, Z Wang², H Chu², S Riddler³, T Brown², A Dobs², B Visscher⁴, and L Kingsley³ ¹Northwestern Univ, Feinberg Sch of Med, Chicago, IL, US; ²Johns Hopkins Univ, Baltimore, MD, US; ³Univ of Pittsburgh, PA, US; and ⁴David Geffen Sch of Med, Univ of California, Los Angeles Med Ctr, US
748	Metabolic Syndrome in HIV within a Representative US Patient Population Kristin Mondy*¹, S Tong¹, L Kessels¹, W Powderly², and E Overton¹ ¹Washington Univ Sch of Med, St Louis, MO, US and ²Univ College, Dublin, Ireland
749	Factors Associated with Regional Adipose Tissue in HIV⁺ Women Phyllis Tien*^1,2, P Bacchetti¹, J Cofrancesco³, S Heymsfield⁴, and FRAM Study ¹Univ of California, San Francisco, US; ²VAMC, San Francisco, CA, US; ³Johns Hopkins Univ, Baltimore, MD, US; and ⁴Merck, Rahway, NJ, US
750	Gender and Race/Ethnicity Differences in Dyslipidemia among HIV-infected Patients Participating in the Fat Redistribution and Metabolic Change Cohort Study David Wohl*¹, J Currier², R Scherzer³, D Lee⁴, M Simberkoff⁵, P Tien³, and C Grunfeld³ ¹Univ of North Carolina at Chapel Hill, US; ²David Geffen Sch of Med, Univ of California, Los Angeles Med Ctr, US; ³VAMC, San Francisco, CA, US; ⁴Univ of California, San Diego, US; and ⁵VAMC-New York Harbor Hlthcare System, New York, US
751	Clinical Lipoatrophy Assessment Strongly Correlates with DEXA-measured Limb Fat and Subcutaneous Fat Mitochondrial DNA Levels Grace McComsey*¹, M O'Riordan¹, N Storer¹, S Goldman², J Ganz², D Libutti³, and M Gerschenson³ ¹Rainbow Babies and Childrens' Hosp and Case Western Reserve Univ, Cleveland, OH, US; ²Univ Hosp of Cleveland, OH, US; and ³Univ of Hawaii, Honolulu, US
752	High Sensitivity C-reactive Protein (hs-CRP) and Body Composition in a Cohort of HIV-infected Subject from Nutrition for Healthy Living A Mangili^1,2, A Zampini³, D Jacobson¹, and Christine Wanke*^1,2 ¹Tufts Univ, Boston, MA, US; ²New England Med Ctr, Tufts Univ Sch of Med, Boston, MA, US; and ³Friedman Sch of Nutrition Sci and Policy, Tufts Univ, Boston, MA, US
753	Mitochondrial DNA in Peripheral Blood Does Not Reflect the Mitochondrial Status in Skeletal Muscle in HIV-infected Patients Anne Maagaard*¹, M Holberg-Petersen¹, G Kollberg², A Oldfors², L Sandvik¹, and J Bruun¹ ¹Ullevaal Univ Hosp, Oslo, Norway and ²Sahlgrenska Univ Hosp, Gothenburg, Sweden
754	Assessment of the Agreement between the LDL Genzyme Assay and LDL Measured by Ultracentrifugation and the Applicability of the Friedewald Equation for Calculating LDL Measurements: ACTG A5087 Scott Evans*¹, C Fichtenbaum², W Meyer³, M Caulfield³, J Aberg⁴, and ACTG 5087 Study Team ¹Harvard Sch of Publ Hlth, Boston, MA, US; ²Univ of Cincinnati, OH, US; ³Quest Diagnostics, Baltimore, MD, US; and ⁴New York Univ, NY, US
755	Peripheral and Visceral Fat Changes following a Treatment Switch to a Nonthymidine Analogue or Nucleoside-sparing Regimen in Patients with Peripheral Lipoatrophy: 48-week Final Results of ACTG A5110, a Prospective, Randomized Multicenter Clinical Trial Robert Murphy*¹, J Zhang², R Hafner³, K Yarasheski⁴, K Tashima⁵, B Berzins¹, S Owens⁶, A Shevitz⁷, S Evans², P Tebas⁸, and ACTG A5110 Team ¹Northwestern Univ Med Sch, Chicago, IL, US; ²Harvard Sch of Publ Hlth, Boston, MA, US; ³Div of AIDS, NIAID, NIH, DHHS, Bethesda, MD, US; ⁴Washington Univ, St Louis, MO, US; ⁵Brown Univ, Providence, RI, US; ⁶Frontier Sci & Tech Res Fndn, Amherst, NY, US; ⁷Tufts Univ Sch of Med, Boston, MA, US; and ⁸Univ of Pennsylvania, Philadelphia, US
756	Effect of a Low Dose of Salmon Oil on Triglycerides and Lipid Parameters in HIV Patients Receiving a HAART Regimen and Having Elevated Serum Triglyceride Levels and Total Cholesterol / High Density Lipoprotein Ratio Jean-Guy Baril*¹, C Kovacs², S Trottier³, G Roederer⁴, A Martel⁵, N Ackad⁶, N Longo^7,8, C Liao^7,8, and J Sampalis^7,8 ¹Clin du Quartier Latin, Montréal, Canada; ²Maple Leaf Med Clin, Toronto, Canada; ³Ctr Hosp Univ Laval Res Ctr, Ste-Foy, Canada; ⁴Clin Med L'Actuel, Montréal, Canada; ⁵Ctr Med de Halles Ste-Foy, Canada; ⁶Abbott Labs, Montréal, Canada; ⁷JSS Med Res, Montreal, Canada; and ⁸McGill Univ, Montréal, Canada
757	The Effects of Caloric Restriction on the Hypermetabolism of HIV Lipodystrophy Lisa Kosmiski*, S Stotz, and T Horton Univ of Colorado Hlth Sci Ctr, Denver, US
758	Effect of Prolonged Interruption of ART on Mitochondrial Toxicity Eugenia Negredo*¹, B Rodriguez-Santiago¹, J Puig¹, R Lopez-Blazquez¹, R Ayen², E Martinez-Lopez¹, C Miranda¹, L Ruiz², and B Clotet² ¹Lluita contra la Sida Fndn Germans Trias i Pujol Univ Hosp, Badalona, Spain and ²IrsiCaixa Fndn Germans Trias i Pujol Univ Hosp, Badalona, Spain
759	A Prospective Study of Abnormal Glucose Tolerance among Older Adults with or at-risk for HIV Andrea Howard*, R Klein, M Floris-Moore, J Arnsten, and E Schoenbaum Montefiore Med Ctr, Albert Einstein Coll of Med, Bronx, NY, US
760	Comparison of Diabetes Mellitus Prevalence and Risk Factors among HIV-infected ART-naïve Individuals vs Individuals in the NHANES III Cohort Indira Brar*¹, J Shuter², D Wentworth³, A Thomas³, E Daniels⁴, J Absalon⁵, and Minority and Women's Task Force, Terry Beirn Community Prgms for Clin Res on AIDS ¹Henry Ford Hosp, Detroit, MI, US; ²Montefiore Med Ctr, New York, NY, US; ³Univ of Minnesota, Minneapolis, US; ⁴Social & Sci Systems, Silver Spring, MD, US; and ⁵Columbia Univ Mailman Sch of Publ Hlth, New York, NY, US
761	Diabetes Mellitus in HIV-infected Persons: The Role of CD4 Counts Adeel Butt*^1,2,3,4, D Kelley¹, K McGinnis^2,3,5, M Skanderson^2,3, S Crystal^3,6, M Simberkoff^3,7, M Rodriguez-Barradas^3,8,9, D Leaf^3,10,11, M Goetz^3,10,11, A Justice^3,12,13, and Veterans Aging Cohort Study ¹Univ of Pittsburgh Med Ctr, PA, US; ²VA Pittsburgh Hlthcare System, PA, US; ³Veterans Aging Cohort Study; ⁴Ctr for Hlth Equity Res and Promotion, Pittsburgh, PA, US; ⁵Univ Ctr for Social and Urban Res, Univ of Pittsburgh, PA, US; ⁶Rutgers Univ, New Brunswick, NJ, US; ⁷VA NY Harbor Hlthcare System, US; ⁸Baylor Coll of Med, Houston, TX, US; ⁹Michael E DeBakey VAMC, Houston, TX, US; ¹⁰David Geffen Sch of Med, Univ of California, Los Angeles, US; ¹¹VA Greater Los Angeles Hlthcare System, CA, US; ¹²Yale Univ, New Haven, CT, US; and ¹³VA Hlthcare System, West Haven, CT, US
762	Factors Associated with Reduced Bone Mineral Density in HIV-infected Patients; ANRS CO 3 Aquitaine Cohort, France Herve Dutronc*¹, V Lavignolle-Aurillac², R Thiebaut², S Lawson-Ayayi^1,2, N Barthe^1,2, N Mehsen¹, D Lacoste¹, D Neau^1,2, J L Pellegrin^1,2, M Dupon^1,2, and the Groupe d'Epidemiologie Clin du SIDA en Aquitaine ¹Bordeaux Univ Hosp, France and ²Bordeaux Univ, France